0001209191-18-045333.txt : 20180803
0001209191-18-045333.hdr.sgml : 20180803
20180803170330
ACCESSION NUMBER: 0001209191-18-045333
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180801
FILED AS OF DATE: 20180803
DATE AS OF CHANGE: 20180803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Taylor Brenton
CENTRAL INDEX KEY: 0001596103
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36309
FILM NUMBER: 18992709
MAIL ADDRESS:
STREET 1: 326 BOLLAY DRIVE
CITY: GOLETA
STATE: CA
ZIP: 93117
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inogen Inc
CENTRAL INDEX KEY: 0001294133
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 326 BOLLAY DRIVE
CITY: GOLETA
STATE: CA
ZIP: 93117
BUSINESS PHONE: 805-562-0500
MAIL ADDRESS:
STREET 1: 326 BOLLAY DRIVE
CITY: GOLETA
STATE: CA
ZIP: 93117
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-01
0
0001294133
Inogen Inc
INGN
0001596103
Taylor Brenton
C/O INOGEN, INC.
326 BOLLAY DRIVE
GOLETA
CA
93117
0
1
0
0
EVP, Engineering
Common Stock
2018-08-01
4
A
0
5000
44.19
A
41576
D
Common Stock
2018-08-01
4
S
0
600
196.194
D
40976
D
Common Stock
2018-08-01
4
S
0
2000
196.923
D
38976
D
Common Stock
2018-08-01
4
S
0
1000
198.257
D
37976
D
Common Stock
2018-08-01
4
S
0
1200
199.2492
D
36776
D
Common Stock
2018-08-01
4
S
0
200
200.473
D
36576
D
Common Stock
842
I
By Spouse
Stock Option (Right to Buy)
44.19
2018-08-01
4
M
0
5000
0.00
D
2023-05-11
Common Stock
5000
42500
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017.
Represents the weighted average share price of an aggregate total of 600 shares sold in the price range of $195.95 to $196.48 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average share price of an aggregate total of 2,000
shares sold in the price range of $196.60 to $197.46 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average share price of an aggregate total of 1,000
shares sold in the price range of $197.79 to $198.54 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average share price of an aggregate total of 1,200
shares sold in the price range of $198.84 to $199.63 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price
Represents the weighted average share price of an aggregate total of 200
shares sold in the price range of $200.39 to $200.52 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2016.
/s/ Alison Bauerlein, as Attorney-in-Fact
2018-08-03